Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

4 recruiting1 with results

Enrollment Performance

Analytics

Phase 2

4(50.0%)

N/A

2(25.0%)

Phase 1

1(12.5%)

Phase 3

1(12.5%)

8Total

Phase 2(4)

N/A(2)

Phase 1(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07157735Phase 2Recruiting

A Trial to Test the Use of Dapansutrile, an Anti-inflammatory Medication, in People With Parkinson's Disease

Role: collaborator

NCT03439943Phase 2Completed

Study to Evaluate the Effect of Lixisenatide in Patient With Parkinson's Disease

Role: collaborator

NCT07207057Phase 3Recruiting

Edmond J. Safra Accelerating Clinical Trials in Parkinson's Disease: A Multiarm Multi-stage Platform Trial

Role: collaborator

NCT06339034Phase 1Active Not Recruiting

Repurposing Lithium for Parkinson's Disease: a RCT

Role: collaborator

NCT06993142Not ApplicableNot Yet Recruiting

Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage

Role: collaborator

NCT06193252Not ApplicableRecruiting

Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands

Role: collaborator

NCT02953665Phase 2Completed

Safety and Efficacy of Liraglutide in Parkinson's Disease

Role: collaborator

NCT06151002Recruiting

PD Frontline (Part of RAPSODI GD) Remote Assessment of People With Parkinson's

Role: collaborator

NCT02941822Phase 2Completed

Ambroxol in Disease Modification in Parkinson Disease

Role: collaborator

All 9 trials loaded